Muscles don’t grow bigger by filling up with water or glycogen—they grow by adding more of the actual contractile parts that make them strong.
Scientific Claim
Sarcoplasmic hypertrophy—defined as disproportionate expansion of non-contractile muscle components—is not a meaningful or consistent contributor to long-term muscle growth in humans, with myofibrillar protein accretion remaining the dominant adaptation.
Original Statement
“Evidence for sarcoplasmic hypertrophy as a distinct, functional contributor to muscle growth is weak; myofibrillar protein accretion remains the dominant adaptation... Jorgenson and colleagues strongly refutes sarcoplasmic hypertrophy as an RET-induced adaptation... radial growth of muscle fibers is largely mediated by myofibrillogenesis.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The review uses definitive language ('remains the dominant adaptation') but synthesizes studies with conflicting results. The conclusion is reasonable but not definitively proven by the review’s design.
More Accurate Statement
“Sarcoplasmic hypertrophy—defined as disproportionate expansion of non-contractile muscle components—is unlikely to be a meaningful or consistent contributor to long-term muscle growth in humans, with myofibrillar protein accretion likely remaining the dominant adaptation based on current evidence.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aQuantifies the proportion of muscle growth attributable to myofibrillar vs. sarcoplasmic components across all human studies using advanced imaging or proteomics.
Quantifies the proportion of muscle growth attributable to myofibrillar vs. sarcoplasmic components across all human studies using advanced imaging or proteomics.
What This Would Prove
Quantifies the proportion of muscle growth attributable to myofibrillar vs. sarcoplasmic components across all human studies using advanced imaging or proteomics.
Ideal Study Design
A meta-analysis of all human RCTs using proteomics, TEM, or advanced MRI to quantify myofibrillar and sarcoplasmic volume changes after 8+ weeks of resistance training in 300+ participants.
Limitation: Limited by availability and standardization of advanced measurement techniques.
Randomized Controlled TrialLevel 1bIn EvidenceDemonstrates whether high-volume training induces disproportionate sarcoplasmic expansion compared to high-load training.
Demonstrates whether high-volume training induces disproportionate sarcoplasmic expansion compared to high-load training.
What This Would Prove
Demonstrates whether high-volume training induces disproportionate sarcoplasmic expansion compared to high-load training.
Ideal Study Design
A double-blind RCT of 60 trained men, randomized to 12 weeks of either high-volume (32 sets/week) or high-load (5 sets/week) leg training, with muscle biopsies analyzed for myofibrillar protein density, sarcoplasmic volume, and glycogen content via TEM and proteomics.
Limitation: Cannot fully separate hydration from protein content changes.
Prospective Cohort StudyLevel 2bTracks whether bodybuilders with large muscle size show higher sarcoplasmic:myofibrillar ratios than powerlifters over time.
Tracks whether bodybuilders with large muscle size show higher sarcoplasmic:myofibrillar ratios than powerlifters over time.
What This Would Prove
Tracks whether bodybuilders with large muscle size show higher sarcoplasmic:myofibrillar ratios than powerlifters over time.
Ideal Study Design
A 3-year prospective cohort comparing 50 elite bodybuilders and 50 elite powerlifters using MRI and muscle biopsy to quantify sarcoplasmic volume, myofibrillar density, and strength-to-mass ratios.
Limitation: Confounded by nutrition, steroid use, and training history.
Evidence from Studies
Supporting (1)
Load-induced human skeletal muscle hypertrophy: Mechanisms, myths, and misconceptions.